Skip to main content
ARTL
NASDAQ Life Sciences

ARTELO BIOSCIENCES Discloses $1.76M+ Arbitration Claim, Formalizes $6.53M ATM Offering Amidst Going Concern

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$1.38
Mkt Cap
$3.174M
52W Low
$1.19
52W High
$85.8
52W Position info
16% above low
Off High info
98% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

ARTL sits 16% above its 52-week low of $1.19.

Summary

Artelo Biosciences disclosed a new FINRA arbitration claim seeking over $1.76 million, a substantial liability relative to its market cap, and formalized a highly dilutive $6.53 million ATM offering, further highlighting its precarious financial position.


Key Events · Legal and Risk Events · ARTL

  • Significant Arbitration Claim Disclosed

    The company disclosed a FINRA arbitration claim filed by Craft Capital Management LLC on April 7, 2026, seeking an $880,000 success fee and $880,000 in common stock warrants, plus late fees and attorneys' fees. This claim totals over $1.76 million, representing more than 50% of the company's market capitalization.

  • Formalizes $6.53M At-The-Market Offering

    Artelo Biosciences entered into an At-The-Market (ATM) Offering Agreement with H.C. Wainwright & Co., LLC to sell up to $6.53 million of common stock. This offering, previously announced via a 424B5 filing on the same day, is highly dilutive, representing over 200% of the company's current market capitalization.

  • Ongoing Going Concern Warning

    This financing and legal risk occurs in the context of the company's reiterated 'going concern' warning from its most recent 10-Q filing, indicating substantial doubt about its ability to continue as a going concern.


Analysis · ARTL · Life Sciences

This filing reveals a new and highly material FINRA arbitration claim seeking over $1.76 million in fees and warrants, which represents more than 50% of the company's current market capitalization. This introduces a significant new liability and legal risk. Additionally, the company formalized an At-The-Market (ATM) offering for up to $6.53 million, which is highly dilutive given the company's small market cap and existing 'going concern' warning. While the ATM program was previously announced, this 8-K provides the definitive agreement details, underscoring the company's urgent need for capital and the potential for substantial shareholder dilution.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 52.8% of the 195 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.69%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ARTL was trading at $1.38 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.2M. The 52-week trading range was $1.19 to $85.80. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ARTL - Latest Insights

ARTL
Nov 12, 2026, 8:00 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.24
Real-time Price: $2.04 info
Change: -$0.1999 (-9%) info
Market Cap: $1.94M info
ARTL
Oct 09, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.19
Real-time Price: $2.04 info
Change: -$1.15 (-36%) info
Market Cap: $1.94M info
ARTL
Sep 23, 2026, 1:46 PM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $7.84
Real-time Price: $2.04 info
Change: -$5.80 (-74%) info
Market Cap: $1.94M info
ARTL
Sep 16, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $5.02
Real-time Price: $2.04 info
Change: -$2.98 (-59%) info
Market Cap: $1.94M info
ARTL
Aug 27, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.658
Real-time Price: $2.04 info
Change: Reverse Stock Split info
Market Cap: $1.94M info